News 2020-07-03
The Launching of Official Website for 2020 Pharmaceutical Crystallization Summit
J-Star Research, a wholly owned subsidiary of Porton Pharma Solution Ltd., engages with Xtalpi and a broad selection of industrial and academic leaders to host the 2020 Pharmaceutical Crystallization Summit on October 7th and 8th, 2020 (Live).
We will take a close look at the ever-expanding toolbox of capabilities needed to meet challenges in API crystallization. The Summit will emphasize the importance of understanding fundamentals and root causes of problems to effectively speed up process and product development.
Considering the impact of the Covid-19 outbreak, this year’s Summit will be held online (live). This provides the advantage of allowing more attendees than a normal face-to-face meeting. The registration for invited attendees starts in June, and the registration for the general public starts on August 7th, 2020. Registration Reminder for public audience will be released through Porton official channels in August.
Warmly welcome our customers and investors to follow us on this Summit in the coming months.
Website:
https://crystallization-summit.jstar-research.com/
LinkedIn：
https://www.linkedin.com/company/center-for-pharma-crystallization-cfpc/
Others
More
News 2024-11-13
Porton Has Been Invited to the China–Slovenia Business and Investment Forum and Had a Friendly Meeting with Slovenian Officials.
During the Slovenian government delegation's visit to Shanghai, the Slovenian Consulate in Shanghai and the Shanghai Municipal Commission for Trade Promotion hosted the "China–Slovenia Business and Investment Forum" on November 4th, 2024.
News 2024-11-09
Porton’s New Modality Capacity Upgrade Ceremony Successfully Held
On November 7, 2024, the New Modality Capacity Upgrade Ceremony was successfully held in Fengxian, Shanghai, China. Attendees included Mr. Weng Jun，Vice General Manager，Shanghai Hangzhou Bay Economic & Technological Development Co., Ltd., Mr. Bai Yinchun, COO and Senior Vice President of Porton, Ms. Pi Wei, Vice President and Board Secretary of Porton, Ms. Meng Fan, Deputy General Manager of the Sales & Marketing Center of Porton, and Mr. Xie Lihua, Head of the Synthetic Macromolecules Service Department. Together, they witnessed this significant moment of enhancing the production capacity for new modalities at the Fengxian site.
